TEL AVIV, Israel (BUSINESS WIRE) Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the appointment of Dr. R. Ananthanarayanan (Ananth) as CEO of its Teva Active Pharmaceutical Ingredients business (Teva api). Dr. Ananth will lead the API business starting November 27, 2023, and will be base.
Teva appoints new CEO for Teva api, its Active Pharmaceutical Ingredients Business streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Teva Pharmaceutical Industries Ltd. today announced the appointment of Dr. R. Ananthanarayanan as CEO of its Teva Active Pharmaceutical Ingredients business . Dr. Ananth will lead the API business.
Teva Pharmaceutical Industries Ltd. today announced the appointment of Dr. R. Ananthanarayanan (Ananth) as CEO of its Teva Active Pharmaceutical Ingredients business (Teva api). Dr. Ananth will lead the API business starting November 27, 2023, and.